-
January 22, 2010
Abstract
The adequacy of labeling for instructions, cautions, and contraindications becomes pivotal in the benefit/risk assessment of medical products. Our...
-
January 6, 2010
Coordinating REMS activities between the various functional groups within a pharmaceutical company that are involved in, or are affected by...
-
January 5, 2010
The objective of these periodic REMS knowledge and understanding assessments is to track stakeholder recognition and comprehension of the product...
-
January 1, 2010
A Dear Healthcare Professional (HCP) Letter is a risk communication tool that is often included as an element of a...
